LTRN - Lantern Pharma Inc
2.7
-0.060 -2.222%
Share volume: 31,301
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.06
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | 05-15-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 5.732 M | 5.408 M | 5.180 M | 5.896 M | 4.774 M | 4.350 M | |
| Selling general and admin | 1.481 M | 1.520 M | 1.463 M | 1.627 M | 1.510 M | 1.913 M | |
| Research and development | 4.251 M | 3.889 M | 3.717 M | 4.270 M | 3.264 M | 2.437 M | |
| Total expenses | 5.732 M | 5.408 M | 5.180 M | 5.896 M | 4.774 M | 4.350 M | |
| -5.64% | -4.23% | 13.84% | -19.03% | -8.89% | |||
| Operating income | -5.732 M | -5.408 M | -5.180 M | -5.896 M | -4.774 M | -4.350 M | |
| Ebit | -5.642 M | -5.148 M | -4.697 M | -6.037 M | -4.687 M | -4.278 M | |
| Pretax income | -5.441 M | -4.960 M | -4.506 M | -5.875 M | -4.537 M | -4.177 M | |
| -8.85% | -9.15% | 30.39% | -22.78% | -7.92% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.441 M | -4.960 M | -4.506 M | -5.875 M | -4.537 M | -4.177 M | |
| 8.85% | 9.15% | -30.39% | 22.78% | 7.92% |